Abstract
Sequence variations with biologic effect in ALS have been identified in the gene for vascular endothelial growth factor (VEGF). The gene for a related protein, angiogenin, lies on chromosome 14q11.2. Analysis of the angiogenin (ANG) gene in the authors' population has demonstrated a significant allelic association with the rs11701 single nucleotide polymorphism (SNP) and identified a novel mutation in two individuals with sporadic ALS that potentially inhibits angiogenin function. These observations propose a candidate region for ALS on chromosome 14q11.2 and suggest that other genes with similar function to VEGF may be important in the pathogenesis of ALS.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Alleles
-
Amino Acid Substitution
-
Amyotrophic Lateral Sclerosis / genetics*
-
Chromosome Mapping*
-
Chromosomes, Human, Pair 14 / genetics*
-
Codon / genetics
-
Cohort Studies
-
DNA-(Apurinic or Apyrimidinic Site) Lyase / genetics
-
Female
-
Gene Frequency
-
Genetic Predisposition to Disease
-
Humans
-
Ireland / epidemiology
-
Male
-
Middle Aged
-
Mutation, Missense
-
Point Mutation
-
Polymerase Chain Reaction
-
Polymorphism, Single Nucleotide*
-
Ribonuclease, Pancreatic / genetics*
-
Ribonuclease, Pancreatic / physiology
-
Vascular Endothelial Growth Factor A / physiology
Substances
-
Codon
-
Vascular Endothelial Growth Factor A
-
angiogenin
-
Ribonuclease, Pancreatic
-
APEX1 protein, human
-
DNA-(Apurinic or Apyrimidinic Site) Lyase